Compounds > sorafenib
Page last updated: 2024-09-05

sorafenib and Facial Neoplasms

sorafenib has been researched along with Facial Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Kitamura, S; Maeda, T; Miyamoto, K; Yanagi, T1
Allison, RR; Cavalieri, R; Finley, J; Gay, HA; Quan, WD1

Other Studies

2 other study(ies) available for sorafenib and Facial Neoplasms

ArticleYear
Sorafenib-Related Basal Cell Carcinoma.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2021, 09-01, Volume: 47, Issue:9

    Topics: Aged, 80 and over; Antineoplastic Agents; Carcinoma, Basal Cell; Facial Neoplasms; Humans; Liver Neoplasms; Male; Sorafenib

2021
Complete response in a cutaneous facial metastatic nodule from renal cell carcinoma after hypofractionated radiotherapy.
    Dermatology online journal, 2007, Oct-13, Volume: 13, Issue:4

    Topics: Antineoplastic Agents; Benzenesulfonates; Carcinoma, Renal Cell; Facial Neoplasms; Humans; Interleukin-2; Kidney Neoplasms; Male; Middle Aged; Niacinamide; Palliative Care; Phenylurea Compounds; Pyridines; Remission Induction; Skin Neoplasms; Sorafenib

2007